Cargando…

Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer

High expression of Inhibitor of apoptosis proteins (IAPs) has been related to colorectal cancer (CRC) progression, resistance to treatment and poor prognosis. TRAIL (TNF-related apoptosis-inducing ligand) through its receptors DR4 (TRAIL-R1) and DR5 (TRAIL-R2) can selectively induce cancer cell apop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devetzi, Marina, Kosmidou, Vivian, Vlassi, Margarita, Perysinakis, Iraklis, Aggeli, Chrysanthi, Choreftaki, Theodosia, Zografos, Georgios N., Pintzas, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101514/ https://www.ncbi.nlm.nih.gov/pubmed/27827395 http://dx.doi.org/10.1038/srep36532

Ejemplares similares

Haemorrhage in pre-existing adrenal masses. A case series
por: Nixon, Alexander M., et al.
Publicado: (2020)

Metastatic leiomyosarcoma of the intrapancreatic bile duct
por: Perysinakis, Iraklis, et al.
Publicado: (2013)

BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells
por: Goulielmaki, Maria, et al.
Publicado: (2016)

Total gastrectomy for the treatment of Menetrier’s disease persistent to medical therapy: A case report
por: Parianos, Christos, et al.
Publicado: (2020)

Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
por: Bychkov, Maxim L., et al.
Publicado: (2014)

The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms
por: Angelousi, Anna, et al.
Publicado: (2021)

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
por: Qiao, Chunxia, et al.
Publicado: (2012)

Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population
por: Megas, Georgios, et al.
Publicado: (2015)

Expression of proto-oncogene c-Myc in patients with urinary bladder transitional cell carcinoma
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression
por: Kim, Seok, et al.
Publicado: (2018)

A Coexisting Pilocytic Astrocytoma and a Prolactinoma: A Case Report of Collision Tumors and Literature Review
por: Malli, Antonia, et al.
Publicado: (2019)

Primary intrahepatic malignant epithelioid mesothelioma
por: Perysinakis, Iraklis, et al.
Publicado: (2014)

Potentiation of TRAIL-Induced Apoptosis in TRAIL-Resistant Cholangiocarcinoma Cells by Curcumin through the Induction of DR5 Membrane Localization and Disruption of the Anti-Apoptotic Complex DR5/DDX3/GSK3β
por: Visitnonthachai, Daranee, et al.
Publicado: (2023)

Prognostic significance of serum soluble DR5 levels in small-cell lung cancer
por: Wan, Zhenfa, et al.
Publicado: (2019)

Detection of Anticancer and Apoptotic Effect of the Produced IgYs against the Three Extracellular Domain of Human DR5 Protein
por: Amirijavid, Shaghayegh, et al.
Publicado: (2015)

Primary pigmented nodular adrenocortical disease presenting with a unilateral adrenocortical nodule treated with bilateral laparoscopic adrenalectomy: a case report
por: Zografos, George N, et al.
Publicado: (2010)

Laparoscopic Resection of Large Adrenal Tumors
por: Zografos, George N., et al.
Publicado: (2010)

First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
por: Wang, Shujing, et al.
Publicado: (2021)

Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
por: Thodou, Eleni, et al.
Publicado: (2019)

CMS Physics panel for P5 visits
por: Lapka, Marzena
Publicado: (10-0)

CMS Physics panel for P5 visits
por: Davis, Siona Ruth
Publicado: (2016)

Summary of Panel Discussion 5: Coherent Instabilities
por: Vaccaro, V G, et al.
Publicado: (2005)

Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma
por: Kang, Zhigang, et al.
Publicado: (2012)

CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018)

Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo
por: Oikonomou, E, et al.
Publicado: (2007)

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
por: Dubuisson, Agathe, et al.
Publicado: (2017)

Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation
por: Yoon, Ji Yun, et al.
Publicado: (2021)

Conozca a DR DOS 5.0
por: Schieb, Joerg
Publicado: (1992)

Dr Quain's Anatomy; 5th Edition
Publicado: (1846)

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
por: Oh, You-Take, et al.
Publicado: (2017)

Correction to: CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018)

Just 5 agencies can use datacentre panel
Publicado: (2009)

Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury
por: Zhao, Danyang, et al.
Publicado: (2023)

Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends
por: Zografos, George N, et al.
Publicado: (2010)

Development of the maize 5.5K loci panel for genomic prediction through genotyping by target sequencing
por: Ma, Juan, et al.
Publicado: (2022)

Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors
por: Artykov, Artem A., et al.
Publicado: (2020)

Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5
por: Kamalabadi-Farahani, Mohammad, et al.
Publicado: (2019)

Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells
por: Yagolovich, Anne, et al.
Publicado: (2021)

Measurements on Combined 12.5/17.5 Kv Prototype Inductive Adder for the Clic Dr Kickers
por: Holma, J, et al.
Publicado: (2019)

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kb7e8e1g45msllr4qatueurrdr